linkedin
BROUGHT TO YOU BY
Exclusive Access, Inclusive Growth

WELCOME TO ET PRIME

BROUGTH TO YOU BY
Exclusive Access, Inclusive Growth

Pharma + healthcare

1
Pharma

MNCs are in awe of Serum Institute’s clout in vaccines. It’s now on the cusp of raising the bar.

The Pune-based vaccine manufacturer has a track record of taking up the challenge whenever there was a need to deliver vaccines on humanitarian grounds rather than merely for business or profits. Undaunted by strategic and regulatory hurdles, it has pledged to ensure equitable distribution of vaccines against Covid-19 once they are ready for release.

Strategy

Test everyone on earth to end the pandemic before the year ends

Increasing test-kit production and implementing a universal testing strategy is feasible. At $5 per unit, the cost of testing the world’s population every week would come to around $2 trillion. That is far less than the pandemic-related loss of global income during this period. The missing pieces are the industrial policies and other government measures to coordinate and steer production.

15 Oct 20200 comment
Investing

Granules deepens US focus with differentiated products. But sustaining success may not be easy.

Granules has not only had a stellar stock performance but also delivered robust earnings growth. While focusing on its core business, which has high-volume and low-value products, the company has been expanding the product basket to include higher-margin products for the US. However, navigating the challenging business environment for generic drugs in the US could be difficult.

[[^message]]

Result

[[/message]] [[#message]]

[[message]]

[[/message]]